Intuitive Surgical (ISRG) Q1 2025 10-Q Quarterly Report
Filed: Apr 23, 2025Period ending Mar 31, 2025
Health Care
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR Intuitive Surgical (ISRG) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 23, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Intuitive Surgical Q1 2025 10-Q Analysis
Risk Factors
- • No new or materially changed risk factors since 2024 10-K, risks carried forward unchanged
- • Significant regulatory risk from ongoing FDA compliance and approval process for new surgical systems
Intuitive Surgical Q1 2025 Quarterly FinancialsXBRL
Revenue
$2.3B
▲ +19.2% YoY
Net Income
$698M
▲ +28.2% YoY
Gross Margin
64.7%
▼ -118bp YoY
Operating Margin
25.7%
▲ +83bp YoY
Net Margin
31.0%
▲ +217bp YoY
EPS (Diluted)
$1.92
▲ +27.2% YoY
Operating Cash Flow
$582M
▲ +119.1% YoY
Source: XBRL data from Intuitive Surgical Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Intuitive Surgical Quarterly Reports
Get deeper insights on Intuitive Surgical
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.